These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35265530)

  • 21. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.
    Borren NZ; Ghadermarzi S; Hutfless S; Ananthakrishnan AN
    PLoS One; 2017; 12(5):e0176797. PubMed ID: 28463987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients.
    Austin K; Sweet M; Likar E; LaSala PR; Murray A; Wen S; Ross KG; Kanate AS; Veltri L; Matuga R; Cumpston A
    Transpl Infect Dis; 2020 Dec; 22(6):e13438. PubMed ID: 32767807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation.
    Callejas-Díaz A; Gea-Banacloche JC
    Curr Hematol Malig Rep; 2014 Mar; 9(1):85-90. PubMed ID: 24390550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
    Akahoshi Y; Kimura S; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Clin Transplant; 2016 Jun; 30(6):703-8. PubMed ID: 27019071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
    Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients.
    Mani S; Rybicki L; Jagadeesh D; Mossad SB
    Bone Marrow Transplant; 2016 May; 51(5):713-7. PubMed ID: 26726944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.
    Alonso CD; Dufresne SF; Hanna DB; Labbé AC; Treadway SB; Neofytos D; Bélanger S; Huff CA; Laverdière M; Marr KA
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1502-8. PubMed ID: 23916741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
    Dubberke ER; Reske KA; Olsen MA; Bommarito K; Cleveland AA; Silveira FP; Schuster MG; Kauffman CA; Avery RK; Pappas PG; Chiller TM
    Transpl Infect Dis; 2018 Apr; 20(2):e12855. PubMed ID: 29427356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes.
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Nguyen A; Asch J; Hoda D
    Clin Transplant; 2019 Nov; 33(11):e13712. PubMed ID: 31532030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.
    Bruminhent J; Wang ZX; Hu C; Wagner J; Sunday R; Bobik B; Hegarty S; Keith S; Alpdogan S; Carabasi M; Filicko-O'Hara J; Flomenberg N; Kasner M; Outschoorn UM; Weiss M; Flomenberg P
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1329-34. PubMed ID: 24792871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
    Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
    Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
    Lee YJ; Arguello ES; Jenq RR; Littmann E; Kim GJ; Miller LC; Ling L; Figueroa C; Robilotti E; Perales MA; Barker JN; Giralt S; van den Brink MRM; Pamer EG; Taur Y
    J Infect Dis; 2017 Apr; 215(7):1117-1123. PubMed ID: 28498996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.
    Alonso CD; Marr KA
    Curr Opin Infect Dis; 2013 Aug; 26(4):326-31. PubMed ID: 23806895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.
    Ortiz-Balbuena J; Royuela A; Calderón-Parra J; Martínez-Ruiz R; Asensio-Vegas Á; Múñez E; Valencia-Alijo Á; Gutiérrez-Rojas Á; Ussetti P; Cuervas-Mons V; Segovia-Cubero J; Portolés-Pérez J; Ramos-Martínez A
    Transplant Proc; 2021 Dec; 53(10):2826-2832. PubMed ID: 34772488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicted Bezlotoxumab Exposure in Patients Who Have Received a Hematopoietic Stem Cell Transplant.
    de Almeida C; Wong M; Kleijn HJ; Wrishko RE
    Clin Ther; 2023 Apr; 45(4):356-362. PubMed ID: 36906440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile infection in a children's hospital with specific patterns among pediatric oncology and hematopoietic stem cell transplantation populations.
    Spruit JL; Knight T; Sweeney C; Salimnia H; Savaşan S
    Pediatr Hematol Oncol; 2020 Apr; 37(3):211-222. PubMed ID: 31994977
    [No Abstract]   [Full Text] [Related]  

  • 40. Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes.
    Willis DN; Huang FS; Elward AM; Wu N; Magnusen B; Dubberke ER; Hayashi RJ
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):302-308. PubMed ID: 32766672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.